News

EXO-OVARIAN CANCER SCREENING PROGRAM COMPLETES SERUM EQUIVALENCE STUDY

Posted: 11 August 2023 INOVIQ Limited (ASX:IIQ) (INOVIQ or the Company), a developer of next-generation exosome solutions and precision diagnostics, today announced results from an equivalence study to evaluate exosome-based biomarkers and performance of the EXO-OC test algorithm…

First Patient Dosed in Pivotal Phase III Study of TLX591-CDx (Illuccix®) for Prostate Cancer Imaging in Chinese Patients

Posted: 11 August 2023 Telix today announces that a first patient has been dosed in China in the pivotal Phase III registration study of TLX591-CDx (Illuccix®, Kit for the preparation of 68Ga-PSMA-11),[1] for the imaging of prostate cancer using positron…

SUCCESSFUL COMPLETION OF SECOND PLANNED DSMB REVIEW OF ACTION3 PHASE 3 FSGS KIDNEY TRIAL

Posted: 11 August 2023 Dimerix Limited (ASX: DXB) a biopharmaceutical company with late-stage clinical assets in inflammatory diseases, today confirmed that the independent Data Safety Monitoring Board (DSMB) has successfully concluded a second review of the ACTION3 phase…

Firebrick Covid-19 Trial Achieves Primary Endpoint

Posted: 7 August 2023 Firebrick Pharma Limited (ASX:FRE) (Firebrick, Company) is pleased to announce that its Phase 2 trial of Nasodine® Nasal Spray (“Nasodine”) in COVID-19 achieved its primary endpoint. The primary endpoint was the reduction in viral…

Adherium Accelerates Commercialisation with Largest US Allergy & Asthma Practice

Posted: 7 August 2023 Leading digital health company Adherium Limited (ASX:ADR) has signed a collaboration agreement with US–based Allergy Partners to transform asthma management for its more than 300,000 patients across 130 sites in 20 states. Allergy Partners…

AD-214 RETURNS TO CLINICAL STUDIES

Posted: 7 August 2023 AdAlta Limited (ASX:1AD), the clinical stage drug discovery company developing novel therapeutic products using its i-body platform provides an update on its lead fibrosis asset, AD-214. The first participants in the Company’s Phase I…

A mother’s diet can protect her grandchildren’s brains: genetic model study

Posted: 7 August 2023 Mothers who eat apples and herbs in early pregnancy could be protecting the brain health of their children and grandchildren, a Monash University study using genetic models has found. The discovery is part of…

3D digital technologies tackling mental injury prevention in health care

Posted: 7 August 2023 Designers have 3D-knitted bespoke hospital scrubs and 3D printed chill out pods for busy healthcare workers to improve their comfort and workplace mental health. The Safety Sensescaping project, funded by WorkSafe’s WorkWell Mental Health Improvement Fund,…

ACCENT Trial Recruitment Update

Posted: 7 August 2023 Amplia Therapeutics Limited (ASX: ATX), (“Amplia” or the “Company”), is pleased to provide an update on progress in the ongoing Phase 1b/2a ACCENT clinical trial in first-line patients with advanced pancreatic cancer. The current…

$16.7 million vote of confidence in Melbourne-developed cancer detection system

Posted: 7 August 2023 A major investment in a Melbourne-based healthcare technology developer will underpin the launch of a world-first live microscopic imaging device for oral cancer. Optiscan Imaging Limited (ASX: OIL) has developed a miniaturised, handheld technology…

Immutep Receives Positive Scientific Advice from European Medicines Agency

Posted: 7 August 2023 Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for cancer and autoimmune disease, today announces it has received positive scientific advice from the Committee…

$64 million in funding for new ARC Industrial Transformation Training Centres and ARC Industrial Transformation Research Hubs

Posted: 7 August 2023 More than $64.8 million in funding has been awarded to 8 new Australian Research Council (ARC) Industrial Transformation Training Centres and 5 new ARC Industrial Transformation Research Hubs to mentor and train Australia’s next…

Home

News & opinion

Member Directory

Events